We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.1B
AUM Growth
-$3.19M
Cap. Flow
+$7.15M
Cap. Flow %
0.65%
Top 10 Hldgs %
43.88%
Holding
196
New
25
Increased
25
Reduced
18
Closed
22

Top Buys

Rank Stock Value
1
ROCC
Ranger Oil Corporation Class A Common Stock
ROCC
+$19.4M
2
HSACU
Health Sciences Acquisitions Corporation Units
HSACU
+$8.33M
3
ADNT icon
Adient
ADNT
+$5.66M
4
ROAN
Roan Resources, Inc.
ROAN
+$5.33M
5
GM icon
General Motors
GM
+$3.75M

Top Sells

Rank Stock Value
1
QURE icon
uniQure
QURE
+$15.9M
2
PCG icon
PG&E
PCG
+$12.8M
3
STNG icon
Scorpio Tankers
STNG
+$10.5M
4
TRUE
TrueCar
TRUE
+$6.45M
5
BX icon
Blackstone
BX
+$5.95M

Sector Composition

Rank Sector Weight
1 Healthcare 22.77%
2 Consumer Discretionary 14.6%
3 Financials 5.74%
4 Energy 5.41%
5 Communication Services 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEP icon
26
PUT
PepsiCo
PEP
$191B
$13.1M 1.19%
+100,000
New +$12.8M
ALDX icon
27
Aldeyra Therapeutics
ALDX
$95.3M
$12.8M 1.16%
2,125,781
+325,781
+18% +$2.45M
ERII icon
28
Energy Recovery
ERII
$439M
$11.5M 1.04%
1,100,000
– –
MGTX icon
29
MeiraGTx Holdings
MGTX
$1.14B
$11M 1%
432,319
– –
PG icon
30
PUT
Procter & Gamble
PG
$346B
$11M 1%
100,000
– –
IMTX icon
31
Immatics
IMTX
$1.18B
$10M 0.91%
1,000,000
– –
GLMD icon
32
Galmed Pharmaceuticals
GLMD
$4.05M
$9.92M 0.9%
7,500
– –
MGNX icon
33
MacroGenics
MGNX
$254M
$9.08M 0.83%
534,970
+50,000
+10% +$859K
CRESY
34
Cresud
CRESY
$822M
$8.88M 0.81%
904,903
– –
IRS
35
IRSA Inversiones y Representaciones
IRS
$1.31B
$8.75M 0.8%
885,538
– –
KR icon
36
CALL
Kroger
KR
$35.5B
$8.68M 0.79%
400,000
– –
HSACU
37
DELISTED
Health Sciences Acquisitions Corporation Units
HSACU
$8.48M 0.77%
+800,000
New +$8.33M
RACE icon
38
PUT
Ferrari
RACE
$66.8B
$8.07M 0.73%
50,000
+25,000
+100% +$3.6M
MDCO
39
DELISTED
Medicines Co
MDCO
$7.84M 0.71%
215,000
+47,748
+29% +$1.56M
GSAT icon
40
Globalstar
GSAT
$10.2B
$7.4M 0.67%
1,027,719
-46,333
-4% -$363K
INSE icon
41
Inspired Entertainment
INSE
$189M
$6.77M 0.62%
801,824
– –
MDC
42
PUT
DELISTED
M.D.C. Holdings, Inc.
MDC
$6.56M 0.6%
216,000
-108,000
-33% -$3.18M
HCC icon
43
Warrior Met Coal
HCC
$4.26B
$6.4M 0.58%
245,000
– –
FATE icon
44
Fate Therapeutics
FATE
$283M
$6.09M 0.55%
300,000
-95,000
-24% -$1.71M
TRUE
45
DELISTED
TrueCar
TRUE
$6.03M 0.55%
1,104,000
-1,052,191
-49% -$6.45M
MRNS
46
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$5.81M 0.53%
350,000
– –
TSLA icon
47
CALL
Tesla
TSLA
$1.22T
$5.59M 0.51%
+375,000
New +$5.84M
ADMA icon
48
ADMA Biologics
ADMA
$1.97B
$5.51M 0.5%
1,424,378
+619,378
+77% +$2.73M
GIS icon
49
PUT
General Mills
GIS
$19.5B
$5.25M 0.48%
+100,000
New +$5.17M
KG
50
Kestrel Group
KG
$70.1M
$5.04M 0.46%
393,848
– –
1
2
3 4 5

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, 683 Capital Management held 196 positions worth $1.1B, down 0.29% from $1.1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

683 Capital Management's Q2 2019 filing shows 25 new, 25 increased, 18 reduced and 22 closed positions. Its largest new stake was Ranger Oil Corporation Class A Common Stock: 520,000 shares worth $16M. The largest sale was uniQure, an estimated $15.9M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

  • 683 Capital Management's largest Q2 2019 buy was Ranger Oil Corporation Class A Common Stock: 520,000 shares worth $16M.
  • 683 Capital Management added most to Adient in Q2 2019, an estimated $5.66M increase.
  • 683 Capital Management's biggest Q2 2019 reduction was uniQure, cutting an estimated $15.9M.
  • 683 Capital Management fully exited Blackstone in Q2 2019, selling an estimated $5.95M.
  • 683 Capital Management's ten largest holdings make up 44% of its $1.1B portfolio in Q2 2019.
  • 683 Capital Management opened 25 new positions and closed 22 in Q2 2019.
  • 683 Capital Management's portfolio value fell 0.29% quarter-over-quarter to $1.1B.

Based on 683 Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.